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Background/purpose: In spite of the conclusions of the Asymptomatic Carotid Atherosclerosis Study, some clinicians are
still reluctant to recommend carotid endarterectomy (CEA) for patients with asymptomatic>60% carotid stenosis (ACS).
This study analyzes the natural history of 60% to 69% ACS according to ultrasonic plaque morphology and its implication
on treatment.
Patient population and methods: During a 2-year period, patients with 60% to 69% ACS entered into a protocol of carotid
duplex scan surveillance/clinical examination every 6 months. The ultrasonic plaque morphology was classified as
heterogeneous (group A, n 162) or homogeneous (group B, n 229) with HDI 3000/HDI 5000 systems (Advanced
Technology Laboratories, Bothwell, Wash). CEA was done if lesion progressed to>70% stenosis or became symptomatic.
Results: Three hundred eighty-two patients (391 arteries) were followed for a mean interval of 37 months. The
clinical/demographic characteristics were similar for both groups. The incidence rate of future ipsilateral strokes was
significantly higher in group A than in group B: 13.6% versus 3.1% (P  .0001; odds ratio [OR], 5). Similarly, the
incidence rate of all neurologic events (stroke or transient ischemic attack [TIA]) was higher in group A than in group B:
27.8% versus 6.6% (P .0001; OR, 5.5). Progression to>70% stenosis was also higher in group A than in group B: 25.3%
versus 6.1% (P  .0001; OR, 5.2). Forty-four late CEAs (27.2%) were done in group A (16 for stroke, 21 for TIA, and
seven for>70% ACS) versus 13 (5.7%) in group B (five for stroke, seven for TIA, and one for>70% ACS; P .0001; OR,
6.2).
Conclusion: Patients with 60% to 69% ACS with heterogeneous plaque had a higher incidence rate of late stroke, TIA, and
progression to >70% stenosis than patients with homogeneous plaque. Prophylactic CEA for 60% to 69% ACS may be
justified if associated with heterogeneous plaque. (J Vasc Surg 2002;36:437-42.)
In 1995, the Asymptomatic Carotid Atherosclerosis
Study (ACAS) concluded that the combination of carotid
endarterectomy (CEA) and best medical therapy signifi-
cantly reduced the risk of stroke, compared with medical
therapy alone, in patients with60% asymptomatic carotid
stenosis (ACS).1 Despite this landmark study, some clini-
cians are still reluctant to recommend CEA for patients
with 60% ACS.2-5 Several investigators have separately
studied the correlation of carotid plaque morphology and
cerebrovascular symptoms.6-11 It has been suggested that
ultrasonic carotid plaque morphology may be as critical as
severity of stenosis in determination of ischemic neurologic
events and, therefore, important in selection of patients for
CEA. Several studies have shown that hypoechoic plaques
and echolucent lesions are associated with a higher inci-
dence rate of hemispheric cerebrovascular symptoms and
cerebral infarcts than hyperechoic lesions.12-16
No study to date has examined these two entities
(severity of carotid stenosis and carotid plaque morphol-
ogy) simultaneously and their effect on treatment. This
study analyzes the natural history of 60% to 69% ACS
according to duplex ultrasound scan plaque morphology
and the implications regarding treatment.
PATIENT POPULATION AND METHODS
During a 2-year period from July 1997 to June 1999,
patients with 60% to 69% ACS (on the basis of color duplex
ultrasonography) were entered into a protocol of carotid
duplex scan surveillance/clinical examination every 6
months. All patients were scheduled for follow-up visits and
duplex ultrasound scan every 6 months and were instructed
to call their physician if they became symptomatic. All
patients were given one adult aspirin (325 mg) daily, and if
contraindicated, they were given clopidogrel bisulfate, 150
mg initially, then 75 mg daily. CEA was done if the lesion
progressed to 70% stenosis (on the basis of duplex ultra-
sound scan) or if the patient became symptomatic (hemi-
spheric transient ischemic attack [TIA] or stroke). The 70%
stenosis cutoff was used because our duplex scan severity
classification was changed in the last few years to 30%
stenosis, 30% to 49% stenosis, 50% to 59% stenosis, 60% to
69% stenosis, and 70% to 99% stenosis to be compatible
with the North American Symptomatic Carotid Endarter-
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ectomy Trial and the ACAS. Therefore, we no longer used
the category of 80% to 99% stenosis. Hemispheric TIA/
stroke symptoms were considered if the symptoms were refer-
able to the territory appropriate to the affected carotid artery.
Duplex ultrasound scan protocol. Carotid color du-
plex ultrasound scan was performed on all patients at their
initial visit (HDI 3000/HDI 5000 systems, Advanced
Technology Laboratories, Bothwell, Wash). Longitudinal
and cross-sectional images were taken throughout the com-
mon carotid, the extracranial portion of the internal ca-
rotid, and the external carotid arteries bilaterally. The se-
verity of stenosis was determined on the basis of our
previously described criteria.17 The following selected op-
timal criteria with the best positive predictive value (95%)
were used: for 60% to 69% internal carotid artery stenosis,
an internal carotid artery peak systolic velocity (PSV) of
220 cm/s, an internal carotid artery end diastolic velocity
(EDV) of 80 cm/s, an internal carotid/common carotid
artery PSV ratio of4.25, or an internal carotid artery PSV
and EDV of 150 cm/s and 65 cm/s. (These have an overall
accuracy of 90%.) For 70% stenosis, we used an internal
carotid artery PSV of300 cm/s, an internal carotid artery
EDV of 110 cm/s, or an internal carotid artery PSV and
EDV of 150 cm/s and 110 cm/s. (These have an overall
accuracy of 91%.) The measurements of carotid stenosis in
these previously published criteria17 were similar to those of
the ACAS. The appearance of the plaque was classified as
heterogeneous or homogenous.6,18 This was determined
by two different observers, and if differences persisted, a
third observer was used to make the final determination.
The echogenecity of the plaque was expressed as hypo-
echoic, isoechoic, or hyperechoic. An isoechoic plaque was
defined as having the echogenicity of a normal intima
media complex. A hyperechoic plaque was brighter than an
isoechoic plaque, and a hypoechoic plaque was not as bright
as an isoechoic plaque. Heterogeneous plaques were com-
posed of a mixture of hypoechoic, isoechoic, and hypere-
choic lesions, and homogeneous plaques consisted of only
one of the three types of plaques.
Statistical analysis. The data were analyzed, and the
differences between variable groups were determined with
2 test, with a P value of less than .05 considered statistically
significant. The odds ratio (OR) and the 95% CI also were
estimated. A Kaplan-Meier life-table analysis was used to
estimate the freedom from progression of stenosis and
stroke event rates.
RESULTS
Three hundred and ninety-one arteries (382 patients)
were included in this study, with a mean follow-up period
of 37 months (range, 24 to 48 months; mean, 37.4 months
for the homogeneous group and 37.0 months for the
heterogeneous group [P  not significant). The clinical/
demographic characteristics were similar for both the ho-
mogeneous and heterogeneous plaques (Table I). Table II
illustrates the correlation between plaque morphology and
late neurologic events. The ipsilateral stroke rate was sig-
nificantly higher in the heterogeneous plaque group than in
the homogeneous plaque group (13.6% versus 3.1%; P 
.0001; OR, 5). Similarly, there was a statistically higher
incidence rate of ipsilateral TIA and all neurologic events in
the heterogeneous group than in the homogeneous group.
Progression to 70% stenosis was also more common in
the heterogeneous plaque group than in the homogeneous
plaque group. Overall, 25.3% of patients with heteroge-
neous plaques showed progression of stenosis, in contrast
to 6.1% for homogeneous plaques (P  .0001; OR, 5.2;
Table III). Of the 39 heterogeneous plaques that pro-
gressed to 70% stenosis, 17 were associated with ipsilat-
eral strokes and 14 with ipsilateral TIA symptoms. Of the
13 homogeneous plaques, six were associated with ipsilat-
eral strokes and five with ipsilateral TIA. There were two




(n  162) P value OR (95% CI)
Mean age 68 67 NS
Male/female 130/99 89/73 NS 0.93 (0.61, 1.42)
Smoking 128 (56%) 86 (53%) NS 0.89 (0.58, 1.37)
Hypercholesterolemia 89 (39%) 68 (42%) NS 1.14 (0.74, 1.75)
Hypertension 168 (72%) 123 (76%) NS 1.15 (0.70, 1.88)
Coronary artery disease 98 (43%) 73 (45%) NS 1.10 (0.72, 1.68)
Diabetes mellitus 78 (34%) 50 (31%) NS 0.86 (0.55, 1.36)
NS, Not significant.




(n  162) P value OR (95% CI)
Ipsilateral strokes 7 (3.1%) 22 (13.6%) .0001 4.98 (1.98, 14.13)
Ipsilateral TIA 8 (3.5%) 23 (14.2%) .0001 4.57 (1.90, 12.11)
All ipsilateral neurologic events 15 (6.6%) 45 (27.8%) .0001 5.49 (2.84, 11.02)
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internal carotid occlusions in the heterogeneous plaque
group, one associated with ipsilateral stroke and the other
with ipsilateral TIA. There was one internal carotid occlu-
sion in the homogeneous plaque group that was associated
with ipsilateral TIA symptoms. The remaining stroke and
TIA events in Table II were associated with 60% to 69%
stenosis with no progression.
As noted in Table IV, progression was more often
correlated to symptoms (TIA and stroke) regardless of
plaque characteristics; however, heterogeneous plaques
were more likely to progress than homogeneous plaques.
All symptomatic patients had strokes before their next
scheduled 6-month duplex ultrasound scan examinations.
Tables V and VI (online only; Figs 1 and 2) summarize the
life-table analysis of freedom from progression of stenosis
and stroke events for both homogeneous and heteroge-
neous plaques. The freedom from progression of stenosis
rates at 6, 12, 24, 36, and 48 months were 100%, 100%,
99%, 97%, and 91% for the homogeneous group and 100%,
97%, 96%, 89%, and 53% for the heterogeneous group (P
.05). Similarly, the freedom from stroke event rates at 6, 12,
24, 36, and 48 months were 100%, 100%, 99%, 98%, and
96% for the homogeneous group and 100%, 98%, 96%,
91%, and 71% for the heterogeneous group (P  .05).
Of 22 patients who had strokes in the heterogeneous
group, 16 had late CEAs, three died of the stroke, two did
not recover enough from their strokes to consider surgery,
and one refused surgery. Of the seven patients who had
strokes in the homogeneous group, five had late CEAs, one
died of the stroke, and one had no significant recovery.
Of the 23 patients with TIA in the heterogeneous
group, 21 underwent a late CEA, one refused surgery, and
one had carotid percutaneous transluminal balloon angio-
plasty and stenting. In contrast, of the eight patients in the
homogeneous group, seven had late CEAs and one refused
surgery. Overall, 44 late CEAs (27.2%) were done in the
heterogeneous group, in contrast to 13 (5.7%) for the
homogeneous group (P  .0001; OR, 6.2; Table VII).
There were no perioperative strokes among the 57 patients
who had surgery. The remaining 334 arteries had no pro-
gression or symptoms. These 334 arteries had a distribution
of 216 homogeneous (64.6%) and 118 heterogeneous
(35.4%) plaques, compared with the initial distribution of
229 homogeneous (58.5%) and 162 heterogeneous
(41.5%) plaques (P  .0001).
DISCUSSION
This study examines the impact of ultrasonic carotid
plaque morphology on the natural history of 60% to 69%
ACS. Ultrasound scan characteristics of carotid plaques
have been associated with different clinical outcomes.6-10
Tegos et al10 analyzed duplex ultrasound scan images by
interpreting their gray scale median values. Hypoechoic
(echolucent) images and hyperechoic (echogenic) images,
at either end of the spectrum, have respective gray scale
median values of 0 (darkest) to 255 (brightest) gray levels.
Retinal symptoms were mainly associated with hypo-
echoic plaques, asymptomatic plaques were mainly hy-
perechoic, and cerebrovascular symptoms were associated
with intermediate echoic plaques. Sabetai et al8 reported
that plaques that are more hypoechoic and stenotic are
more often associated with hemispheric neurologic events.
Biasi et al9 also concluded that a significant incidence of
brain infarcts, as seen on computed tomographic scan
imaging, occurred in patients with echolucent (hypo-
echoic) carotid lesions.
Plaques also can be characterized as homogeneous or
heterogeneous, the latter being described as a combination
of hyperechoic, hypoechoic, and isoechoic plaques. In a
previous study, we reported that heterogeneous plaques are
more likely to result in plaque hemorrhage and adverse
neurologic sequelae.6 Other investigators have reported
that the volume of intraplaque hemorrhage is essentially the
same in symptomatic and asymptomatic lesions.11
Despite the conclusion of the ACAS, some clinicians
are still reluctant to recommend CEA for patients with
60% ACS.2-5 The results of the ACAS1 also indicated that
there was no increased risk of stroke for patients with 60%
to 79% stenosis compared with those with 80% to 99%
stenosis. This directly contradicts the results of the North
American Symptomatic Carotid Endarterectomy Trial,19
which showed an obvious increase in the incidence rate of
Table IV. Progression versus neurologic symptoms
Number Symptoms P value
Heterogeneous
Progression 41 33 (80%) .0001
No progression 121 12 (10%)
Total 162 45
Homogeneous
Progression 14 12 (86%) .0001
No progression 215 3 (1%)
Total 229 15
Whole Series
Progression 55 45 (82%) .0001
No progression 336 15 (5%)
Total 391 60





(n  162) P value OR (95% CI)
70% stenosis 13 (5.7%) 39 (24.1%) .0001 5.27 (2.62, 11.14)
Occlusion 1 (0.4%) 2 (1.2%) .572 2.85 (0.15, 168.9)
Total 14 (6.1%) 41 (25.3%) .0001 5.20 (2.64, 10.73)
JOURNAL OF VASCULAR SURGERY
Volume 36, Number 3 AbuRahma, Thiele, and Wulu 439
stroke as stenosis progressed. Rockman et al20 concluded
that prophylactic CEA should be offered to asymptomatic
patients only when their degree of stenosis reached 80% or
more. However, their duplex scan criteria followed those
published by the University of Washington, which defines
moderate stenosis from 50% to 79%.21 There is much
confusion surrounding these criteria because the ACAS
protocol measured carotid stenoses differently.
Inzitari et al5 confirmed other studies that found that
increasing degrees of stenosis in asymptomatic patients
increase the risk of stroke; however, this is lower than the
risk in symptomatic patients. They also concluded that
approximately half of strokes that occur in asymptomatic
stenoses are a result of lacunar and cardioembolic events,
which CEA cannot prevent.
Our study specifically examined patients with 60% to
69% ACS with particular interest in the type of carotid
plaque: homogeneous versus heterogeneous. Plaque mor-
phology had a significant effect on the incidence of stroke.
The incidence rate of ipsilateral stroke was significantly
higher in patients with heterogeneous plaques. Also, the
incidence rate of all ipsilateral neurologic events, including
Fig 1. Kaplan-Meier life-table analysis of freedom from progressionto 70% stenosis for homogeneous and hetero-
geneous groups.
Fig 2. Kaplan-Meier life-table analysis of freedom from stroke for homogeneous and heterogeneous groups.
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TIA, was significantly higher in patients with heteroge-
neous plaques. Patients with heterogeneous plaques were
more likely to have progression to 70% stenosis than
those with homogeneous plaques. More CEAs were per-
formed for stroke, TIAs, and progression to70% ACS on
patients with heterogeneous plaques than those with ho-
mogeneous plaques.
One of the limitations of ultrasonic categorization of
plaque morphology is reproducibility.22 Ultrasonography
is a highly technologist-dependent study, with variation
also occurring from machine to machine. The gain setting
must be set appropriately to allow proper visualization of
low-level echoes. In a consensus conference concerning the
morphology and risk of carotid plaque, deBray, Baud, and
Dauzat23 suggested that echo density measurements
should be used to reflect the overall brightness of the
plaque, with the term hyperechoic referring to echogenic
plaques and the term hypoechoic referring to echolucent
plaques. They also suggested that the terms homogeneous
and heterogeneous should be used for plaques of uniform or
nonuniform consistency, respectively, thus expressing their
ultrasonic texture. The reference point to which plaque
echo density should be compared is the sternocleidomas-
toid muscle for isoechoic plaques, the bone of the cervical
vertebrae for hyperechoic plaques, and the blood for hypo-
echoic plaques. Sabetai et al22 have proposed computer-
assisted plaque characterization with B-mode image nor-
malization with digital image processing and found it to be
a reliable method for the objective and quantitative assess-
ment of carotid plaque echo morphology.
It appears that some form of standardization of images
is needed if comparisons between different institutions with
different equipment are to be valid. Nicolaides24 estab-
lished a method of standardization of echographic images
obtained through the computer. This method reelaborates
the gray shadows of the entire image, according to fixed
values given to known components of the image, such as
the blood and adventitia, which are always present and at
the same depth as the carotid plaque. Plaque characteriza-
tion is expressed as a number with the gray scale medium.
This method has now been adapted for a multicenter
natural history study, the asymptomatic carotid stenoses
and risk of stroke, which aims at identifying patients with
asymptomatic internal carotid stenosis at high risk of
stroke. However, computerized analysis of carotid plaque
echodensity is not presently available in commercially used
duplex ultrasound scan instrumentation in the United
States.
CONCLUSION
In our study, patients with 60% to 69% ACS with
heterogeneous plaques had a higher incidence rate of late
ipsilateral stroke, TIA, and progression to 70% stenoses
than patients with homogeneous plaques. Prophylactic
CEA for 60% to 69% ACS may be justified if it is associated
with heterogeneous plaques.
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DISCUSSION
Dr Dennis F. Bandyk (Tampa, Fla). My friend Dr Abu-
Rahma and his colleagues have recommended carotid endarterec-
tomy be performed on asymptomatic patients with heterogeneous
plaque and 60% stenosis by duplex scan criteria, but would this
approach have decreased stroke in their patients? Unfortunately,
the study design did not permit this question to be answered. What
the clinical data did show is that the development of stroke or TIA
was primarily associated with disease progression to a greater than
70% stenosis or occlusion. Only 1.3% of the patients developed
stroke without disease progression, and only 2.5% of patients with
heterogeneous plaques without disease progression. By compari-
son, greater than 70% of the patients with or without heteroge-
neous plaques and disease progression developed neurologic syn-
dromes or ICA occlusion. This incidence of disease progression of
13% is similar to the University of Washington study for progres-
sion of 50% to 79% stenosis to greater than 80% stenosis of 16% at
4 years. Since the goal of duplex surveillance in carotid endarter-
ectomy is to prevent stroke, we need to identify those patients at
highest risk for progression and intervene before the stroke occurs.
Eight percent of the patients in this study developed a stroke
despite duplex surveillance and antiplatelet therapy. Of interest,
this incidence of stroke for this 60% to 69% category is similar to
ACAS medical group of 11%, but in that group, two thirds of the
patients had more severe ICA stenosis on entry. Our experience
and the University of Washington experience have been an annual
unheralded stroke risk of about 1% in this duplex category. My
questions, Ali, are:
Isn’t disease progression to a more severe stenosis more im-
portant than having a heterogeneous plaque? And did you identify
any features of the heterogeneous plaque that predicted those
patients that are likely to progress or those patients that developed
unheralded stroke? What was the morbidity of the 57 patients who
underwent endarterectomy? Was this similar to the ACAS study
morbidity? And lastly, I think you need to tell us what are the
duplex scan criteria that are necessary to recommend carotid
endarterectomy? Would you change your criteria now by looking
back at the duplex scan findings in the patients that developed
symptomatic disease, in particular the ones that had unheralded
stroke?
I would like to thank the society for the opportunity to review
the paper and ask Ali these questions.
Dr Ali F. AbuRahma. Thank you, Dennis, for your com-
ments and questions. It was not my intention to convey to the
audience that they should operate on patients with 60% symptom-
atic carotid stenosis. This study was designed to help some of those
in the audience who are hesitant to operate on asymptomatic
carotid stenosis. Our study simply concludes that if the plaque is
heterogeneous, it is more likely to progress and more likely to be
associated with a stroke. Therefore, heterogenicity may be another
parameter to consider when making a decision as to whether or not
you should proceed with surgery.
In regards to your first question as to whether disease progres-
sion or severity of stenosis is more critical, this is difficult to answer.
Based on our data, even if stroke symptoms were associated once
the artery progressed, keep in mind that most of these stroke
patients presented with a stroke prior to their next routine duplex
ultrasound. Therefore, they presented with symptoms before they
had a test to indicate that their disease had progressed. Also,
heterogeneous plaques were more likely to progress than homo-
geneous plaques.
In regards to your question about the morbidity of the 57
patients who underwent carotid endarterectomy, there was no
perioperative stroke in either group in this study.
In regard to the duplex scan criteria that were necessary to
recommend carotid endarterectomy, we used the duplex criteria
with a positive predictive value of 95% in selecting patients with
60% stenosis.
Dr Charles Kiell (Hickory, NC). I have two questions. First
of all, do you have any thoughts about standardization of your
scans to adjust for any variations in gray scale?
Second, with the behavior of the heterogeneous plaques, have
you made any changes in recommendations about antiplatelet
medications?
Dr AbuRahma. In response to your first questions regarding
standardization, I do not have a specific reply to this, except that
there is presently no standardization in regards to carotid plaque in
most commercially available duplex instrumentation in the United
States.
In regards to your second question about the behavior of the
heterogeneous plaques and any recommendations about antiplat-
let therapy, we have not made any different recommendations than
the usual, giving patients antiplatelet therapy such as aspirin and
Plavix.
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Table V, online only. Life-table analysis: Freedom from progression to 70% stenosis
Interval (mo)
Number at risk





Entry 229 0 100% 0
6 228 0 100% 0
12 222 1 99.6% 0.4%
18 222 0 99.6% 0.4%
24 220 1 99.1% 0.6%
30 193 3 97.7% 1.0%
36 139 1 97.1% 1.2%
42 61 6 92.3% 2.3%
48 8 1 90.8% 2.7%
48 1 1 79.4% 10.9%
Heterogeneous group
Entry 162 0 100% 0
6 162 0 100% 0
12 154 5 96.9% 1.4%
18 154 0 96.9% 1.4%
24 151 1 96.3% 1.5%
30 124 6 92.3% 2.1%
36 84 4 88.5% 2.8%
42 29 20 62.7% 5.7%
48 5 4 52.9% 6.7%
48 5 1 35.3% 11.1%
Table VI, online only. Life-table analysis: Freedom from stroke
Interval (mo)
Number at risk





Entry 229 0 100% 0
6 228 0 100% 0
12 222 1 99.6% 0.4%
18 222 0 99.6% 0.4%
24 220 1 99.1% 0.6%
30 193 2 98.2% 0.9%
36 139 1 97.5% 1.1%
42 61 0 97.5% 1.1%
48 8 1 95.9% 1.9%
48 1 1 84% 11.3%
Heterogeneous group
Entry 162 0 100% 0
6 162 0 100% 0
12 154 4 97.5% 1.2%
18 154 0 97.5% 1.2%
24 151 2 96.3% 1.5%
30 124 2 94.9% 1.7%
36 84 4 91% 2.6%
42 29 5 83.6% 4.1%
48 6 3 71% 7.7%
48 5 2 47.4% 14.6%
